Eli Lilly shot helped patients lose 29% of body weight
Trial results are a boost to US pharmaceutical company’s booming obesity business
Related reading
Eli Lilly’s weight-loss pill meets target in key diabetes trial
Results from US pharma group show oral drug reduced body weight by 10.5% on average
Eli Lilly wins US approval for weight-loss drug in pill form
New drug Foundayo sets up battle with Novo Nordisk for oral obesity drugs
Eli Lilly becomes first pharma group to join $1tn club
Shares have soared more than 40% this year over strong demand for weight-loss and diabetes drugs
The race to launch a pill for weight loss
Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of…
Weight-loss drugs are bringing a new commercial reality
The reinforcing feedback loop that has long powered the food industry is being chemically switched off
Pharma just ‘scratching the surface’ of weight-loss drug market
Novo Nordisk chief estimates industry reaching only 15% of potential customers at most